Alicia Morgans
Member of the Faculty of Medicine at Harvard Medical School
Biography
Harvard Medical School
Alicia Morgans is a Genitourinary Medical Oncologist and the Medical Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported outcome measures, as well as incorporating patient preferences and beliefs into clinical decision making. Her research has investigated complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications. Her work has been funded by grants from the Prostate Cancer Foundation and the Department of Defense. She is a member of the advanced and localized prostate cancer treatment guidelines committee of the American Urologic Association, and is a member of the cardio-oncology committee of the American Heart Association. Since 2016, she has been President of the Medical Advisory Board for ZERO, a non-profit organization dedicated to supporting education and research funding for prostate cancer research.
Clinical Interests
- Cancer survivorship
- Quality of life
- Shared decision making
Education
- University of Pennsylvania School of Medicine - Doctor of Medicine (M.D.) 2002 - 2006
- Vanderbilt University School of Medicine - Master of Public Health (M.P.H.) 2013 - 2015
- Harvard Medical School - Massachusetts General Hospital - Fellowship, Hematology/Oncology 2009 - 2012
- Hospital of the University of Pennsylvania - Internal Medicine Residency Program 2006 - 2009
- Ursinus College - Bachelor’s Degree, Biology and Spanish 1998 - 2002
Videos
Alicia Morgans, MD, MPH | Biggest Takeaway at 2018 Best of ASCO St. Louis
Prostate Cancer Working Group 3 (PCWG3) Criteria in Clinical Trials
Survivorship In Prostate Cancer | Alicia Morgans
Updates on Management of Metastatic Hormone-Sensitive Prostate Cancer
FDA-approved Indications for Treatment Versus Use in Current Clinical Trials
Increase in Bladder Cancer
Prostate Cancer Treatment Decisions: Which Path is Best for YOU?
M0 CRPC: Treatment Options and Emerging Concepts
Seeking Optimal Prostate Cancer Care? The Importance of Partnering With A Specialist
Alicia Morgans, MD, MPH on genitourinary cancer treatment and Dana-Farber's survivorship program
Understanding the Evolving Treatment Landscape in Prostate Cancer
Recognizing and Managing Side Effects of Androgen Deprivation Therapy (ADT)
Women in Prostate Cancer Research - Dr. Alicia Morgans
Spotting False Claims: Tips for Identifying Prostate Cancer Misinformation
Alicia Morgans, MD, MPH | What's exciting in Prostate Cancer at 2018 Best of ASCO St. Louis
Read about executive education
Other experts
Popular Courses
The Positive Leader: Deep Change and Organizational Transformation
Stephen M. Ross School of Business
Ann Arbor, Michigan, United States
Jun 23
The Manchester Leadership Development Programme
Alliance Manchester Business School
Manchester, United Kingdom
Jul 1
Private Equity: Investing and Creating Value
The Wharton School
Philadelphia, Pennsylvania, United States
Sep 8
Leading People and Teams
ESMT
Berlin, Germany
May 28
Leading Strategic Growth and Change
Columbia Business School
New York, New York, United States
Jun 10
Leading Digital Transformation
ESMT
Berlin, Germany
May 28
Looking for an expert?
Contact us and we'll find the best option for you.